Torrent Pharma Receives Final Listing Approval for 4.19 Cr Equity Shares Post JB Chemicals Amalgamation
Torrent Pharmaceuticals Limited has received final listing and trading approval for 4,19,22,416 equity shares. These shares were allotted following the amalgamation of J. B. Chemicals & Pharmaceuticals Limited. The shares will be listed and traded on NSE and BSE effective July 28, 2026.
The listing of new shares post-amalgamation is a significant corporate event that impacts the company's capital structure and shareholder base, hence considered medium impact.
The company has successfully received the final listing and trading approval for the equity shares issued post-amalgamation, which is a positive development indicating the completion of the corporate action.
Torrent Pharmaceuticals Limited announced on 27th July, 2026, that it has received the Final Listing and Trading Approval from the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) for 4,19,22,416 fully paid-up Equity Shares. These shares were issued and allotted in terms of the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited. This follows the earlier intimation dated 20th July, 2026, regarding the allotment of these Equity Shares to eligible Shareholders of JB Chemicals as of the Record Date, Friday, 17th July, 2026.
The aforesaid Equity Shares of Torrent Pharmaceuticals Limited will be listed and admitted to dealings on both NSE and BSE effective from 28th July, 2026.
What to do with a filing like this
Torrent Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under amalgamation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Torrent Pharmaceuticals Limited. Read the original for the full detail.